SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-23-055487
Filing Date
2023-05-03
Accepted
2023-05-03 16:06:14
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-1 tm2314345-1_f1.htm F-1 545959
2 EXHIBIT 5.1 tm2314345d2_ex5-1.htm EX-5.1 39333
3 EXHIBIT 23.3 tm2314345d2_ex23-3.htm EX-23.3 3441
4 EX-FILING FEES tm2314345d2_ex-filingfees.htm EX-FILING FEES 30377
5 GRAPHIC lg_addextherapeutics-4clr.jpg GRAPHIC 68193
6 GRAPHIC tm2314345d2_ex5-1img001.jpg GRAPHIC 1472
7 GRAPHIC tm2314345d2_ex5-1img002.jpg GRAPHIC 825
  Complete submission text file 0001104659-23-055487.txt   712633
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-271611 | Film No.: 23883681
SIC: 2834 Pharmaceutical Preparations